Relay Therapeutics Inc banner

Wall St Price Targets

RLAY Price Forecast
Based on 15 analysts

+42% Upside
from $19.72 today

Relay Therapeutics Inc (RLAY)’s 12-month stock price forecast through November 2027 has a consensus target of $28.05, implying 42% upside. The forecast is based on price targets from 15 Wall Street analysts.

RLAY Analyst Rating
Based on 13 analysts

avg. 4.77 of 5
Strong buy
10 77%
Buy
3 23%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

Analysts rate RLAY Strong buy, with 13 of 13 recommending Buy or Strong buy.

Relay Therapeutics Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RLAY's stock price target?
Price Target
28.05 USD

According to Wall Street analysts, the average 1-year price target for RLAY is 28.05 USD with a low forecast of 18.21 USD and a high forecast of 33.6 USD.

What is the Revenue forecast for Relay Therapeutics Inc?
Projected CAGR
77%

The compound annual growth rate for Revenue over the next 8 years is 77%.

Back to Top